Chemed (NYSE:CHE) Announces Quarterly Earnings Results, Misses Estimates By $0.12 EPS
Chemed (NYSE:CHE – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12), Briefing.com reports. Chemed had a net margin of 12.88% and a return on equity of 29.90%. The business had revenue of $595.88 million during the quarter, […]
More Stories
BRP Inc. (TSE:DOO) Given Consensus Rating of “Hold” by Brokerages
Shares of BRP Inc. (TSE:DOO – Get Free Report) have received a consensus rating of “Hold” from the twelve brokerages...
Critical Comparison: Solaris Energy Infrastructure (NASDAQ:SEI) versus Drilling Tools International (NASDAQ:DTI)
Drilling Tools International (NASDAQ:DTI – Get Free Report) and Solaris Energy Infrastructure (NASDAQ:SEI – Get Free Report) are both small-cap...
The Role of Analytics in Online Radio Station Software
In today’s technology-driven era, where the digital landscape transforms how people interact with media content, radio stations have become a...
EOR or In-House HR to Handle Global Employment?
Venturing into global markets is an exciting yet challenging prospect for many businesses. Strategic HR decisions can help hugely influence...
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) have received an average recommendation of “Moderate Buy” from the nine...
Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Consensus Recommendation of “Buy” by Analysts
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have earned an average rating of “Buy” from the thirteen...